Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-19 Sale |
2023-05-23 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
65 | $19.5 | $1,268 | 22,204 (Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
1,090 | $19.59 | $21,356 | 22,269 (Direct) |
View |
| 2023-05-05 Sale |
2023-05-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $20.87 | $46,957 | 143,639 (Direct) |
View |
| 2023-05-08 Sale |
2023-05-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $21.8 | $224,160 | 225,874 (Direct) |
View |
| 2023-05-03 Sale |
2023-05-05 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus SENIOR VICE PRESIDENT, CMC |
759 | $20.79 | $15,779 | 0 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,693 | $20.63 | $323,745 | 403,381 (Direct) |
View |
| 2023-04-21 Sale |
2023-04-25 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $19.5 | $78,000 | 22,068 (Direct) |
View |
| 2023-04-06 Sale |
2023-04-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $18.17 | $186,829 | 234,867 (Direct) |
View |
| 2023-04-05 Sale |
2023-04-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $18.2 | $40,942 | 145,889 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $19.39 | $290,916 | 418,381 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,282 | $23.73 | $243,954 | 245,150 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $23.75 | $53,440 | 148,139 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $23.81 | $357,196 | 433,381 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $24.59 | $252,881 | 317,432 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $24.27 | $54,612 | 212,389 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $22.68 | $340,197 | 448,381 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $25.98 | $267,203 | 265,716 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $26.4 | $59,405 | 152,639 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $27.07 | $406,076 | 463,381 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-14 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,059 | $29.43 | $60,591 | 205,577 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
13,969 | $28.43 | $397,193 | 148,243 (Direct) |
View |
| 2022-12-08 Sale |
2022-12-12 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,394 | $22.74 | $236,310 | 415,666 (Direct) |
View |
| 2022-12-07 Sale |
2022-12-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
23,648 | $21.85 | $516,782 | 210,111 (Direct) |
View |
| 2022-12-06 Sale |
2022-12-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
40,000 | $17.67 | $706,772 | 288,453 (Direct) |
View |
| 2022-12-05 Sale |
2022-12-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $17.38 | $39,114 | 154,889 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 7:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $18 | $270,000 | 478,381 (Direct) |
View |
| 2022-11-30 Sale |
2022-12-02 7:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
85 | $19.06 | $1,620 | 98,253 (Direct) |
View |
| 2022-11-23 Sale |
2022-11-28 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,261 | $19.07 | $24,048 | 98,338 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-22 8:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,037 | $19.43 | $20,151 | 295,227 (Direct) |
View |
| 2022-11-09 Sale |
2022-11-14 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
21,998 | $18.87 | $415,085 | 777,996 (Direct) |
View |
| 2022-11-07 Sale |
2022-11-09 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
26,000 | $18.24 | $474,351 | 635,422 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-19 Exercise |
2023-05-23 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
65 | $0 | 22,204 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-23 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
65 | $1.74 | 22,204 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
1,090 | $0 | 22,269 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
1,090 | $1.74 | 22,269 (Direct) |
View |
| 2023-05-05 Exercise |
2023-05-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 143,639 (Direct) |
View |
| 2023-05-05 Exercise |
2023-05-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 143,639 (Direct) |
View |
| 2023-05-05 Exercise |
2023-05-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 143,639 (Direct) |
View |
| 2023-05-08 Exercise |
2023-05-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 225,874 (Direct) |
View |
| 2023-05-08 Exercise |
2023-05-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $0 | 225,874 (Direct) |
View |
| 2023-05-08 Exercise |
2023-05-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 225,874 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 403,381 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 403,381 (Direct) |
View |
| 2023-04-21 Exercise |
2023-04-25 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $0 | 22,068 (Direct) |
View |
| 2023-04-21 Exercise |
2023-04-25 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $1.74 | 22,068 (Direct) |
View |
| 2023-04-06 Exercise |
2023-04-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 234,867 (Direct) |
View |
| 2023-04-06 Exercise |
2023-04-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 234,867 (Direct) |
View |
| 2023-04-06 Exercise |
2023-04-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 234,867 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 145,889 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 145,889 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 145,889 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 418,381 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 418,381 (Direct) |
View |
Ownership |
2023-03-08 6:01 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Pigot Timothy Chief Commercial Officer |
0 | $0 | 182,960 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-08 6:00 pm |
N/A 2033-03-06 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
139,067 | $0 | 139,067 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,870 | $2.14 | 245,150 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,282 | $0 | 245,150 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 245,150 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 148,139 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 148,139 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 148,139 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 433,381 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 433,381 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-08 6:10 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus SENIOR VICE PRESIDENT, CMC |
62,000 | $0 | 62,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-08 6:10 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
85,000 | $0 | 85,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-08 6:10 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
62,000 | $0 | 63,960 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-08 6:00 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
62,000 | $0 | 317,432 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,872 | $2.14 | 317,432 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $0 | 317,432 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 317,432 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-08 6:00 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
62,000 | $0 | 212,389 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 212,389 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 212,389 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 212,389 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 448,381 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 448,381 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:02 pm |
N/A 2033-01-18 |
Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director |
25,000 | $0 | 27,519 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:02 pm |
N/A 2033-01-18 |
Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director |
2,519 | $15.48 | 27,519 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 265,716 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
40,001 | $0 | 265,716 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 265,716 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 152,639 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 152,639 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 152,639 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:00 pm |
N/A 2033-01-02 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
2,654 | $18.08 | 2,654 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:00 pm |
N/A 2033-01-02 |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
2,627 | $18.08 | 2,627 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 463,381 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 5:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 463,381 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,059 | $2.14 | 205,577 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,059 | $0 | 205,577 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
13,969 | $2.14 | 148,243 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
13,969 | $0 | 148,243 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-12 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,394 | $2.14 | 415,666 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-12 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,394 | $0 | 415,666 (Direct) |
View |
| 2022-12-07 Exercise |
2022-12-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
23,648 | $2.14 | 210,111 (Direct) |
View |
| 2022-12-07 Exercise |
2022-12-09 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
23,648 | $0 | 210,111 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
37,588 | $2.14 | 288,453 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
40,000 | $0 | 288,453 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 288,453 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 154,889 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 154,889 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 154,889 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 7:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 478,381 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 7:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 478,381 (Direct) |
View |
| 2022-11-30 Exercise |
2022-12-02 7:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
85 | $2.14 | 98,253 (Direct) |
View |
| 2022-11-30 Exercise |
2022-12-02 7:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
85 | $0 | 98,253 (Direct) |
View |
| 2022-11-23 Exercise |
2022-11-28 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,261 | $2.14 | 98,338 (Direct) |
View |
| 2022-11-23 Exercise |
2022-11-28 5:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,261 | $0 | 98,338 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-22 8:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,037 | $2.14 | 295,227 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-22 8:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,037 | $0 | 295,227 (Direct) |
View |
| 2022-11-09 Exercise |
2022-11-14 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
21,998 | $2.14 | 777,996 (Direct) |
View |
| 2022-11-09 Exercise |
2022-11-14 5:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
21,998 | $0 | 777,996 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
23,587 | $2.14 | 635,422 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 5:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
25,999 | $0 | 635,422 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 635,422 (Direct) |
View |